At GenBiosis, our clinical trial team is committed to providing comprehensive, high-quality services to support the entire lifecycle of clinical trials. We offer a wide range of early-phase services provided by our trained professional team. These services can be accessed as part of an integrated program or as standalone offerings at our site.
The services offered by GenBiosis include:
– Phase I, II, III, and IV trials
– New Chemical Entity (NCE) support, including Investigational New Drug (IND) applications, 505(b)(2) submissions, IND studies, and Pre-IND meeting support
– Feasibility assessments
– Regulatory submissions and attendance at regulatory meetings
– Project management
– Site selection and management
– Data management and statistical analysis